Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

All Eyes on Sprinklr’s Upcoming Earnings Report

Felix Baarz by Felix Baarz
August 29, 2025
in Stocks
0
Sprinklr Stock
0
SHARES
318
VIEWS
Share on FacebookShare on Twitter

Investors in Sprinklr (NYSE: CXM) are bracing for a pivotal week as the customer experience software provider prepares to release its quarterly results. The upcoming earnings announcement, scheduled for Wednesday before market open, is widely anticipated to determine whether the stock’s recent upward trajectory can be sustained or if it will retreat once more.

Financial Projections and Market Expectations

For its second quarter of fiscal year 2026, Wall Street anticipates Sprinklr will report revenue of $205.39 million with earnings per share of $0.10. The company faces a high bar, having previously exceeded expectations last quarter by posting $0.12 EPS against projections of $0.10, while also slightly surpassing revenue forecasts with $205.50 million. Sprinklr’s own guidance calls for earnings of $0.10 per share on revenue between $205 million and $206 million, figures the market now expects the company to deliver.

Divergent Signals from Market Participants

A notable contrast has emerged between analyst sentiment and institutional investor activity. The current consensus rating among market experts stands at “Hold,” with 47% of the 15 covering firms recommending investors maintain their positions. Only 27% advocate buying shares, while 13% advise selling. This cautious stance was reinforced in early August when Wall Street Zen downgraded its assessment from “Buy” to “Hold.”

Should investors sell immediately? Or is it worth buying Sprinklr?

Institutional investors, however, appear more optimistic. Charles Schwab Investment Management increased its stake by 4.0% during the second quarter, bringing its total holdings to over one million Sprinklr shares. Other significant buyers included Susquehanna Fundamental Investments, Tudor Investment Corp, and Nuveen Asset Management, with the latter expanding its position by a substantial 139.6%.

Strategic Developments and Market Position

Beyond the financial metrics, market participants will be monitoring the company’s strategic direction. Recent executive changes, including the departure of the Chief Accounting Officer and the appointment of a new Head of Global Services, may provide additional context for the company’s operational focus. Furthermore, CEO Rory Read’s scheduled appearance at the Citi Global TMT Conference the day after earnings could offer further insights into the company’s roadmap.

From a technical perspective, Sprinklr shares are positioned at a critical juncture. Having recovered significantly from their 52-week lows, the stock now approaches key moving averages that could determine its near-term direction. The upcoming earnings release will likely determine whether the current upward trend gathers momentum or validates analyst concerns.

Ad

Sprinklr Stock: Buy or Sell?! New Sprinklr Analysis from February 7 delivers the answer:

The latest Sprinklr figures speak for themselves: Urgent action needed for Sprinklr investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Sprinklr: Buy or sell? Read more here...

Tags: Sprinklr
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Eli Lilly Stock
Stocks

Eli Lilly’s Strategic Diversification Amid Weight-Loss Drug Competition

November 18, 2025
Micron Stock
Stocks

Micron Shares Approach Peak: What Comes After the AI Rally?

November 18, 2025
Varonis Stock
Stocks

Varonis Shares Plunge Amidst Mixed Signals

November 18, 2025
Next Post
Illinois Tool Works Stock

Illinois Tool Works: A Study in Market Contradictions

Esperion Therapeutics Stock

Esperion Therapeutics Secures Long-Term Market Exclusivity in Landmark Deal

Prudential Stock

A Sleeping Giant Awakens: Prudential Financial's Strategic Pivot

Recommended

C3.ai Stock

Is C3.ai Stock Poised for a Rebound?

2 months ago
MMM stock news

Clarification on Hyperlink and Promotional Fees

2 years ago

XOMA Corporation Expands Portfolio with Acquisition of DSUVIA

2 years ago
Microsoft Stock

A Bold Bet: Peter Thiel’s Hedge Fund Doubles Down on Microsoft

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

ServiceNow Shares Face Market Skepticism Despite Record Performance

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

A New Chapter for First Busey as CrossFirst Merger Finalizes

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Trending

Avanos Medical Stock
Analysis

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

by SiterGedge
February 7, 2026
0

Avanos Medical is navigating a critical strategic transformation. The medical device firm is streamlining its operations to...

Guaranty Bancshares Stock

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

February 7, 2026
Yirendai Stock

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026
ServiceNow Stock

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
Orthofix Medical Stock

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth
  • Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion
  • Yirendai Charts a New Course with Tech-Driven Strategy

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com